AUTHOR: Fred F. Ferri, MD
Malabsorption is the diminished intestinal absorption of dietary nutrients. The majority of malabsorption is due to either congenital or acquired defects in the membrane transport system, absorption, and brush border processing in the intestinal epithelium.
|
TABLE 1 Cardinal Clinical Features of Specific Malabsorptive Disorders
Disorder | Cardinal Clinical Features | ||
---|---|---|---|
Adrenal insufficiency | Skin darkening, hyponatremia, hyperkalemia | ||
Amyloidosis | Renal disease, nephrotic syndrome, cardiomyopathy, neuropathy, carpal tunnel syndrome, macroglossia, hepatosplenomegaly | ||
Bile acid deficiency | Ileal resection or disease, liver disease | ||
Carcinoid syndrome | Flushing, cardiac murmur | ||
Celiac disease | Variable symptoms: Dermatitis herpetiformis, alopecia, aphthous mouth ulcers, arthropathy, neurologic symptoms, and (life-threatening) malnutrition; elevated liver biochemical test levels, mild iron deficiency | ||
Crohn disease | Arthritis, aphthous mouth ulcers, episcleritis, uveitis, pyoderma gangrenosum, erythema nodosum, abdominal mass, fistulas, perianal fistulae, primary sclerosing cholangitis (PSC), laboratory signs of inflammation | ||
CF | Chronic sinopulmonary disease, meconium ileus, distal intestinal obstruction syndrome (DIOS), elevated sweat chloride | ||
Cystinuria, Hartnup disease | Kidney stones, dermatosis | ||
Diabetes mellitus | Long history of diabetes and diabetic complications | ||
Disaccharidase deficiency | Bloating and cramping, intermittent diarrhea | ||
GI fistulas | Previous intestinal surgery or trauma, Crohn disease | ||
Glucagonoma | Migratory necrolytic erythema, enlarged gallbladder | ||
Hyperthyroidism, hypothyroidism | Symptoms and signs of thyroid disease | ||
Hypogammaglobulinemia | Recurrent infections | ||
Intestinal ischemia | Other ischemic organ manifestations; abdominal pain with eating (chronic mesenteric ischemia) | ||
Lymphoma | Enlarged mesenteric or retroperitoneal lymph nodes, abdominal mass, abdominal pain, fever | ||
Mastocytosis | Urticaria pigmentosum, peptic ulcer | ||
Mycobacterium avium complex infection | AIDS | ||
Pancreatic insufficiency | History of pancreatitis, abdominal pain, or alcoholism; large-volume fatty, oily stools; passage of orange oil | ||
Parasitic infection | History of travel to endemic areas | ||
PBC | Jaundice, itching | ||
Scleroderma | Dysphagia, inability to open the mouth widely, Raynaud phenomenon, skin tightening | ||
SIBO | Previous intestinal surgery, motility disorder (scleroderma, pseudo-obstruction), small intestinal diverticula, strictures | ||
Tropical sprue | History of travel to endemic area | ||
Tuberculosis | Specific history of exposure, living in or travel to endemic area, immunosuppression, abdominal mass or intestinal obstruction, ascites | ||
Whipple disease | Lymphadenopathy, fever, arthritis, cerebral symptoms, heart murmur (pulmonary valve), oculomasticatory myorhythmia | ||
ZES | Peptic ulcers, diarrhea |
AIDS, Acquired immunodeficiency syndrome; CF, cystic fibrosis; GI, gastrointestinal; PBC, primary biliary cholangitis; SIBO, small intestinal bacterial overgrowth; ZES, Zollinger-Ellison syndrome.
From Feldman M et al: Sleisenger and Fordtrans gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.
TABLE 2 Mechanisms of Malabsorption, Malabsorbed Substrates, and Representative Causes
Pathophysiologic Mechanism | Malabsorbed Substrate(s) | Representative Causes |
---|---|---|
Maldigestion | ||
Conjugated bile acid deficiency | Fat Fat-soluble vitamins Calcium Magnesium | Hepatic parenchymal disease Biliary obstruction SIBO with bile acid deconjugation Ileal bile acid malabsorption CCK deficiency |
Pancreatic insufficiency | Fat Protein Carbohydrate Fat-soluble vitamins Vitamin B12 (cobalamin) | Congenital defects Chronic pancreatitis Pancreatic tumors Inactivation of pancreatic enzymes (e.g., ZES) |
Reduced mucosal digestion | Carbohydrate | Congenital defects Acquired lactase deficiency |
Protein | Generalized mucosal disease (e.g., celiac disease, Crohn disease) | |
Intraluminal consumption of nutrients | Vitamin B12 (cobalamin) | SIBO Helminthic infections (e.g., Diphyllobothrium latum infection) |
Malabsorption | ||
Reduced mucosal absorption | Fat Protein Carbohydrate Vitamins Minerals | Congenital transport defects Generalized mucosal diseases (e.g., celiac disease, Crohn disease) Previous intestinal resection or bypass Infections Intestinal lymphoma |
Decreased transport from the intestine | Fat Protein | Intestinal lymphangiectasia Primary Secondary (e.g., solid tumors, Whipple disease, lymphomas) Venous stasis (e.g., from heart failure) |
Other Mechanisms | ||
Decreased gastric acid and/or intrinsic factor secretion | Vitamin B12 | Pernicious anemia Atrophic gastritis Previous gastric resection |
Decreased gastric mixing and/or rapid gastric emptying | Fat Calcium Protein | Previous gastric resection Autonomic neuropathy |
Rapid intestinal transit | Fat | Autonomic neuropathy Hyperthyroidism |
CCK, Cholecystokinin; SIBO, small intestinal bacterial overgrowth; ZES, Zollinger-Ellison syndrome.
From Feldman M et al: Sleisenger and Fordtrans gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.
TABLE E3 Malabsorptive Diseases or Conditions in Which Noninvasive Tests Can Establish Malabsorption or Provide a Diagnosis
Disease or Condition | Diagnostic Test(s) | Comment(s) |
---|---|---|
Lactose malabsorption | Lactose hydrogen breath test Lactose tolerance test | Tests do not differentiate between primary and secondary lactose malabsorption. |
Incomplete fructose absorption | Fructose hydrogen breath test | |
SIBO | 14C-D-xylose breath test Glucose hydrogen breath test Schilling test with and without antibiotics | A predisposing factor should be sought if the result of any of the tests is positive. |
Bile acid malabsorption | SeHCAT test, 14C-TCA test | Does not differentiate between primary and secondary causes. |
Exocrine pancreatic insufficiency | Quantitative fecal fat determination | Used to establish malabsorption in chronic pancreatitis. |
Fecal elastase or chymotrypsin, tubeless tests | Variable sensitivity and specificity, depending on the type of test and stage of the disease. | |
Vitamin B12 malabsorption | Schilling test | The test is performed without intrinsic factor and, depending on the result with intrinsic factor, with antibiotics or pancreatic enzymes. Further tests are necessary if SIBO, terminal ileal disease, or pancreatic disease is suspected. |
SeHCAT,Selenium-75-homotaurocholic acid test; SIBO, small intestinal bacterial overgrowth; TCA, taurocholic acid.
From Feldman M et al: Sleisenger and Fordtrans gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.
TABLE 4 Useful Laboratory Tests for Patients With Suspected Malabsorption and for Establishing Possible Nutrient Deficiencies
Test | Comment(s) | ||
---|---|---|---|
Blood Cell Count | |||
Hematocrit, hemoglobin | Decreased in iron, vitamin B12, and folate malabsorption or with blood loss | ||
Mean corpuscular hemoglobin or mean corpuscular volume | Decreased in iron malabsorption; increased in folate and vitamin B12 malabsorption | ||
White blood cells, differential | Decreased in vitamin B12 and folate malabsorption; low lymphocyte count in lymphangiectasia | ||
Biochemical Tests (Serum) | |||
TGs | Decreased in severe fat malabsorption | ||
Cholesterol | Decreased in bile acid malabsorption or severe fat malabsorption | ||
Albumin | Decreased in severe malnutrition, lymphangiectasia, protein-losing enteropathy | ||
Alkaline phosphatase | Increased in calcium and vitamin D malabsorption (severe steatorrhea); decreased in zinc deficiency | ||
Calcium, phosphorus, magnesium | Decreased in extensive small intestinal mucosal disease, after extensive intestinal resection, or in vitamin D deficiency | ||
Zinc | Decreased in extensive small intestinal mucosal disease or intestinal resection | ||
Iron, ferritin | Decreased in celiac disease, in other extensive small intestinal mucosal diseases, and with chronic blood loss | ||
Other Serum Tests | |||
Prothrombin time | Prolonged in vitamin K malabsorption | ||
β-Carotene | Decreased in fat malabsorption from hepatobiliary or intestinal diseases | ||
Immunoglobulins | Decreased in lymphangiectasia, diffuse lymphoma | ||
Folic acid | Decreased in extensive small intestinal mucosal diseases, with anticonvulsant use, in pregnancy; may be increased in SIBO | ||
Vitamin B12 | Decreased after gastrectomy, in pernicious anemia, terminal ileal disease, SIBO, and infection with Diphyllobothrium latum | ||
Methylmalonic acid | Markedly elevated in vitamin B12 deficiency | ||
Homocysteine | Markedly elevated in vitamin B12 or folate deficiency | ||
Citrulline | May be decreased in destructive small intestinal mucosal disease or intestinal resection | ||
Stool Tests | |||
Fat | Qualitative or quantitative increase in fat malabsorption | ||
Elastase, chymotrypsin | Decreased concentrations and output in exocrine pancreatic insufficiency | ||
pH | Less than 5.5 in carbohydrate malabsorption |
SIBO, Small intestinal bacterial overgrowth; TGs, thyroglobulins.
From Feldman M et al: Sleisenger and Fordtrans gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.
Involves identification and treatment of the underlying illness, treatment of diarrhea, and nutritional repletion
Celiac Disease (Related Key Topic)
Crohn Disease (Related Key Topic)
Cystic Fibrosis (Related Key Topic)
Irritable Bowel Syndrome (Related Key Topic)
Lactose Intolerance (Related Key Topic)
Chronic Pancreatitis (Related Key Topic)
Short Bowel Syndrome (Related Key Topic)
Small Bowel Intestinal Bacterial Overgrowth (Related Key Topic)
Ulcerative Colitis (Related Key Topic)